XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2018/06/29/biogen-increases-ownership-stake-in-samsung-bioepis/20%Monthly2018-06-29 18:08
https://www.bigmoleculewatch.com/2018/06/28/judge-sets-trial-date-in-janssen-v-celltrion-should-summary-judgment-be-denied/20%Monthly2018-07-25 14:10
https://www.bigmoleculewatch.com/2018/06/28/deal-watch-lupin-and-mylan-announce-partnership-to-commercialize-etanercept-biosimilar/20%Monthly2018-06-28 19:25
https://www.bigmoleculewatch.com/2018/06/26/fda-announces-early-communications-program/20%Monthly2018-06-27 00:58
https://www.bigmoleculewatch.com/2018/06/25/scotus-permits-lost-foreign-profit-damages/20%Monthly2018-06-28 15:06
https://www.bigmoleculewatch.com/2018/06/25/deal-watch-acon-investments-and-humus-capital-acquire-biosidus-2/20%Monthly2018-06-28 19:37
https://www.bigmoleculewatch.com/2018/06/25/deal-watch-oncobiologics-enters-into-first-cdmo-contract/20%Monthly2018-06-28 19:38
https://www.bigmoleculewatch.com/2018/06/22/scheduling-order-entered-in-amgen-v-adello-filgrastim-biosimilar-litigation/20%Monthly2018-07-25 14:12
https://www.bigmoleculewatch.com/2018/06/21/new-bpcia-complaint-genentech-sues-amgen-over-proposed-trastuzumab-biosimilar/20%Monthly2018-06-27 12:45
https://www.bigmoleculewatch.com/2018/06/21/genentech-seeks-to-dismiss-and-strike-amgens-counterclaims-and-certain-defenses-in-bevacizumab-biosimilar-litigation/20%Monthly2018-07-25 14:12
https://www.bigmoleculewatch.com/2018/06/21/fda-withdraws-draft-guidance-regarding-statistical-approaches-to-evaluate-analytical-similarity-of-biosimilars/20%Monthly2018-06-21 19:49
https://www.bigmoleculewatch.com/2018/06/20/vermont-and-connecticut-enact-interchangeable-biosimilar-substitution-bills/20%Monthly2019-04-17 17:36
https://www.bigmoleculewatch.com/2018/06/20/big-molecule-watch-editor-nick-mitrokostas-to-speak-at-aci-annual-biosimilars-summit/20%Monthly2018-06-28 15:46
https://www.bigmoleculewatch.com/2018/06/20/updates-on-discovery-rulings-in-abbvie-v-bi-adalimumab-litigation-2/20%Monthly2018-07-25 14:13
https://www.bigmoleculewatch.com/2018/06/19/lupin-and-nichi-iko-collaborate-to-market-etanercept-biosimilar-in-japan/20%Monthly2018-06-27 12:52
https://www.bigmoleculewatch.com/2018/06/18/rituximab-trastuzumab-abatacept-ipr-updates/20%Monthly2018-06-19 15:10
https://www.bigmoleculewatch.com/2018/06/15/celltrion-healthcare-presents-research-demonstrating-positive-results-for-use-of-biosimilar-infliximab-in-treatment-of-crohns-disease-and-rheumatoid-arthritis/20%Monthly2018-06-16 00:22
https://www.bigmoleculewatch.com/2018/06/14/samsung-bioepis-and-biogen-announces-pooled-analysis-of-three-anti-tnf-biosimilars/20%Monthly2018-06-28 19:39
https://www.bigmoleculewatch.com/2018/06/13/updates-on-discovery-rulings-in-abbvie-v-bi-adalimumab-litigation/20%Monthly2018-07-11 16:14
https://www.bigmoleculewatch.com/2018/06/12/new-ipr-petitions-filed-against-gsk-vaccine-process-patents/20%Monthly2018-06-19 15:12
https://www.bigmoleculewatch.com/2018/06/08/samsung-bioepis-reports-new-safety-data-for-trastuzumab-biosimilar/20%Monthly2018-06-28 15:13
https://www.bigmoleculewatch.com/2018/06/07/walgreen-and-kroger-file-remicade-antitrust-action-against-jj/20%Monthly2018-06-26 19:13
https://www.bigmoleculewatch.com/2018/06/06/fda-announces-new-draft-guidance-on-meetings-regarding-the-development-and-review-of-biosimilar-or-interchangeable-products/20%Monthly2018-06-19 15:15
https://www.bigmoleculewatch.com/2018/06/05/rituximab-and-adalimumab-ipr-updates/20%Monthly2018-06-19 15:16
https://www.bigmoleculewatch.com/2018/06/05/biosimilar-regulatory-submission-updates/20%Monthly2018-06-19 15:38
https://www.bigmoleculewatch.com/2018/06/04/breaking-news-u-s-fda-approves-first-pegfilgrastim-biosimilar/20%Monthly2018-06-04 21:29
https://www.bigmoleculewatch.com/2018/06/01/fda-releases-two-draft-guidances-on-rems/20%Monthly2018-06-04 12:59